Oncology
PACLIENT 100
Injection — 100mg/16.7 ml
WHO-GMP
Product Overview
Paclitaxel Injection USP 100 mg/16.7 mL is a potent antineoplastic (anticancer) medication that belongs to the taxane family of chemotherapeutic agents.
Indications
Paclitaxel Injection USP 100 mg/16.7 mL is a chemotherapy medication indicated for treating ovarian, breast, lung, and AIDS-related Kaposi's sarcoma, either as a single agent or in combination therapies.
Dosage Forms & Strength
Available Forms
Injection
Strength
100mg/16.7 ml
Regulatory Approvals
WHO-GMP